| Dr Stephen J Kavka, MD | |
|
4001 Kresge Way, Suite 315, Louisville, KY 40207-4640 | |
| (502) 216-3700 | |
| Not Available |
| Full Name | Dr Stephen J Kavka |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 4001 Kresge Way, Louisville, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396899373 | NPI | - | NPPES |
| 1051839 | Other | KY | PASSPORT |
| 4409578 | Other | KY | AETNA |
| 50019069 | Other | KY | PASSPORT INDIVIDUAL ID # |
| 000000048441 | Other | KY | BLUE CROSS |
| 240006152 | Other | KY | RAILROAD MEDICARE |
| 64353501 | Medicaid | KY |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen J Kavka, MD 4001 Kresge Way, Suite 315, Louisville, KY 40207-4640 Ph: (502) 216-3700 | Dr Stephen J Kavka, MD 4001 Kresge Way, Suite 315, Louisville, KY 40207-4640 Ph: (502) 216-3700 |
News Archive
Researchers at the University of Pittsburgh School of Medicine have identified a new gene responsible for a rare, inherited form of sudden cardiac arrest, known as Brugada syndrome.
North Central Cancer Treatment Group (NCCTG) researchers, based at Mayo Clinic in Rochester, Minn., report that a novel application of the drug vorinostat shows activity in patients with recurrent glioblastoma multiforme.
The Lancet examines Indonesia's efforts to reduce maternal mortality, one of the Millennium Development Goals President Susilo Bambang Yudhoyono has identified as a national priority.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
PDS Biotechnology Corporation today announced that the company has completed GLP toxicology studies of its lead HPV-cancer product. The studies, which included pharmacokinetic (PK) and adsorption, bio-distribution and excretion (ADE) studies in addition to the evaluation of toxicity, all demonstrated a very safe profile of the drug and PDS Biotech's platform Versamune((TM)) technology.
› Verified 6 days ago
Warren C Breidenbach, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 225 Abraham Flexner Way, Ste 700, Louisville, KY 40202 Phone: 502-561-4359 Fax: 502-561-4221 | |
Dale M. Roberts, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 201 Abraham Flexner Way, Suite 1105, Louisville, KY 40202 Phone: 502-581-9223 Fax: 502-581-9225 | |
Donald Alexander Graham, MD FRCSC Plastic Surgery Medicare: Medicare Enrolled Practice Location: 225 Abraham Flexner Way, Suite 850, Louisville, KY 40202 Phone: 502-562-0312 | |
Stephanie Mosley, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 127 Fairfax Ave, Louisville, KY 40207 Phone: 502-897-1601 Fax: 502-893-2937 | |
Ms. Katherine Lynn Billue, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 9880 Angies Way Ste 110, Louisville, KY 40241 Phone: 502-446-6160 Fax: 502-446-6161 | |
Dr. Michael Bradley Calobrace, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2341 Lime Kiln Ln, Louisville, KY 40222 Phone: 502-899-9979 | |
Dr. Marc J Salzman, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4702 Chamberlain Ln, Louisville, KY 40241 Phone: 502-425-5200 Fax: 502-425-7900 |